Skip to content

Clinical trials

Atrial Fibrillation trials with no applicable phase and unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atrial Fibrillation Phase: Not applicable Status: Unknown status Clear all

287 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20073
20084
20091
20109
20118
201213
20138
20149
201515
201616
201720
201821
201930
202025
202130
202232
202325
202415

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status287

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Yonsei University12
Shanghai Chest Hospital10
Royal Brompton & Harefield NHS Foundation Trust7
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine6
The First Affiliated Hospital with Nanjing Medical University5
Eastbourne General Hospital4
Texas Cardiac Arrhythmia Research Foundation4
The Second Affiliated Hospital of Chongqing Medical University4
China National Center for Cardiovascular Diseases3
Maastricht University Medical Center3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrial Fibrillation287
Arrhythmias, Cardiac24
Cardiovascular Diseases11
Heart Failure11
Stroke11
Atrial Flutter8
Hypertension8
Ischemic Stroke8
Heart Diseases5
Heart Valve Diseases4

Trials

Showing 1 to 25 of 287. Each trial links to its page on Pharma Observatory.

187 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.